Digital Integration And Expanded Lung Diagnostics Will Broaden Markets

Published
03 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$1.75
77.4% undervalued intrinsic discount
15 Aug
US$0.40
Loading
1Y
-77.2%
7D
-1.0%

Author's Valuation

US$1.8

77.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 8.38%

Shared on24 Apr 25
Fair value Decreased 40%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.3%.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 78%

AnalystConsensusTarget has increased revenue growth from 18.8% to 24.5%, increased future PE multiple from 58.3x to 99.5x and increased shares outstanding growth rate from 0.0% to 0.1%.